UTAH MEDICAL PRODUCTS, INC. Business Combination, Acquisition Related Costs
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Business Combination, Acquisition Related Costs of $35.00 thousand for the 3-month period ending 2011-06-30, per its 10-Q filed 2012-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2012-08-08
- UTAH MEDICAL PRODUCTS, INC. business combination, acquisition related costs for the quarter ending 2011-06-30 was $35.00K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month |
|---|---|---|
| 2011-06-30 | $35.00K 10-Q · filed 2012-08-08 | $285.00K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |